Back to Search
Start Over
130O The phase III, randomized, double-blind, placebo-controlled KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma.
- Source :
-
Annals of Oncology . 2023 Supplement 4, Vol. 34, pS1521-S1522. 2p. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 34
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 173758149
- Full Text :
- https://doi.org/10.1016/j.annonc.2023.10.266